dronabinol has been researched along with Inflammatory Bowel Diseases in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Bar-Lev Schleider, L; Konikoff, FM; Lish, I; Naftali, T; Ringel, Y; Sklerovsky Benjaminov, F | 1 |
| Baldasso, GM; Bicca, MA; Capasso, R; Dutra, RC; Gonçalves, ECD; Paes, RS | 1 |
| Dunford, J; Lee, AT; Morgan, MM | 1 |
| Konikoff, FM; Naftali, T | 1 |
| Ambrose, T; Simmons, A | 1 |
| Florek, E; Piekoszewski, W; Tkaczyk, M | 1 |
| Bawa, M; Fichna, J; Makriyannis, A; McCafferty, DM; Sharkey, KA; Storr, M; Thakur, GA; Tichkule, R | 1 |
| Goyal, H; Gupta, U; May, E; Singla, U | 1 |
| Moyer, MP; Robertson, DA; Ward, SG; Wright, KL | 1 |
4 review(s) available for dronabinol and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Terpenoids, Cannabimimetic Ligands, beyond the
Topics: Alzheimer Disease; Anxiety; Bicyclic Monoterpenes; Cannabidiol; Cannabinoid Receptor Agonists; Cannabis; Cognitive Dysfunction; Dronabinol; Humans; Inflammatory Bowel Diseases; Neuralgia; Neuroprotective Agents; Nootropic Agents; Schizophrenia; Sesquiterpenes; Terpenes | 2020 |
Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
Topics: Administration, Inhalation; Analgesics, Non-Narcotic; Animals; Cannabinoids; Cannabis; Dronabinol; Endocannabinoids; Humans; Inflammatory Bowel Diseases; Phytotherapy; Plant Extracts; Polymorphism, Single Nucleotide; Receptors, Cannabinoid | 2019 |
[Marihuana and cannobinoids as medicaments].
Topics: Arthritis, Rheumatoid; Cannabidiol; Cannabinoids; Cannabis; Contraindications; Dronabinol; Drug Combinations; Humans; Inflammatory Bowel Diseases; Multiple Sclerosis; Muscle Spasticity; Nausea; Nervous System Diseases; Pain; Plant Extracts; Vomiting | 2012 |
Role of cannabis in digestive disorders.
Topics: Abdominal Pain; Anorexia; Cannabis; Digestive System Diseases; Dronabinol; Endocannabinoids; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Liver Cirrhosis; Medical Marijuana; Nausea; Pancreatic Diseases; Receptors, Cannabinoid; Vomiting | 2017 |
5 other study(ies) available for dronabinol and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Medical cannabis for inflammatory bowel disease: real-life experience of mode of consumption and assessment of side-effects.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; C-Reactive Protein; Cannabidiol; Dronabinol; Drug Administration Routes; Employment; Female; Humans; Immunologic Factors; Inflammatory Bowel Diseases; Israel; Male; Medical Marijuana; Mesalamine; Middle Aged; Patient Reported Outcome Measures; Patient Satisfaction; Prospective Studies; Serum Albumin; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Weight Gain; Young Adult | 2019 |
Tetrahydrocannabinol (THC) Exacerbates Inflammatory Bowel Disease in Adolescent and Adult Female Rats.
Topics: Age Factors; Animals; Behavior, Animal; Cannabinoid Receptor Agonists; Disease Models, Animal; Dronabinol; Female; Inflammatory Bowel Diseases; Rats; Rats, Sprague-Dawley; Running; Symptom Flare Up | 2021 |
Cannabis in Inflammatory Bowel Diseases: from Anecdotal Use to Medicalization?
Topics: Cannabinoids; Dronabinol; Endocannabinoids; Gastrointestinal Tract; Humans; Inflammatory Bowel Diseases; Treatment Outcome | 2017 |
Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors.
Topics: Animals; Cannabinoids; Dronabinol; Inflammatory Bowel Diseases; Macrophages; Male; Mice; Phagocytosis; Receptors, Cannabinoid | 2014 |
Long term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer.
Topics: Adenoma; Anti-Obesity Agents; Apoptosis; Carcinoma; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dronabinol; Drug Inverse Agonism; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2008 |